Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mylan Bertek Pharmaceuticals
This was a pilot, phase II, double-blind, randomized, muticenter, active-comparator, five treatment parallel group dosing and mechanistic study. The study consisted of two phases: 1) screen/washout/single-blind placebo run-in and 2) randomization/treatment. There was a minimum of five scheduled study visits.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
An average sitting diastolic blood pressure (DBP) of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline
You may not be if
Recent myocardial infarction or stroke
Secondary Hypertension
Contraindications to beta-blocker therapy or stopping prior antihypertensive therapy